CN205067498U - Kit for detecting anti -HAV (hepatitis A virus) igG (immunoglobulin G) - Google Patents

Kit for detecting anti -HAV (hepatitis A virus) igG (immunoglobulin G) Download PDF

Info

Publication number
CN205067498U
CN205067498U CN201520782601.2U CN201520782601U CN205067498U CN 205067498 U CN205067498 U CN 205067498U CN 201520782601 U CN201520782601 U CN 201520782601U CN 205067498 U CN205067498 U CN 205067498U
Authority
CN
China
Prior art keywords
reagent bottle
hepatitis
lid
box body
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201520782601.2U
Other languages
Chinese (zh)
Inventor
于水玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201520782601.2U priority Critical patent/CN205067498U/en
Application granted granted Critical
Publication of CN205067498U publication Critical patent/CN205067498U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The utility model relates to an immunoassay medical science field specifically is a kit for detecting anti -HAV (hepatitis A virus) igG (immunoglobulin G), including box body and lid, the bottom is equipped with the reagent bottle portion of placing in the box body, be equipped with a plurality of standing grooves in the portion of placing, the standing groove is enclosed by the riser, the riser slides along the spout on the box body side, box body and box cover inner surface all are equipped with the heat preservation, be equipped with heating device in the lid, be equipped with the power in the lid, still be equipped with temperature sensor in the lid, temperature sensor and heating device are connected. The utility model discloses the size of adjustable standing groove, convenient not the firm of equidimension reagent bottle is placed, the utility model discloses a heat preservation and heating device can promote the temperature in the kit.

Description

For detecting the kit of hepatitis A virus IgG antibody
Technical field
The utility model relates to field of immunoassay medicine, is specially a kind of kit for detecting hepatitis A virus IgG antibody.
Background technology
Hepatitis A is propagated by hepatitis A virus (HAV) a kind of communicable disease based on liver damage caused by fecal oral route.Be a kind of RNA virus, belong to pico+ribonucleic acid+virus section, be enterovirus 72 type, diameter spherical in shape is about 27nm, forms symmetrical 20 body nucleocapsids, include line style single-stranded RNA by 32 shell particulates.HAV has 4 major polypeptide, for forming the many skins of major antigen of virus coat protein, induces neutralizing antibody.HAV is present in the blood of patient, ight soil and liver endochylema.After infecting, in serum, Anti-HAV IgM antibody occurs very soon, reaches peak at about 2 weeks.Then declining gradually, disappeared within 8 weeks, is the serological evidence of HAV recent infection; Anti-HAVIgG antibody produces more late, occurs that (when IgM starts to decline, IgG rises gradually) belongs to protection antibody in early days, reach peak, can exist lastingly, can protect human body no longer subinfection in convalescence in later stage acute stage and convalescence; Significant to hepatitis A epidemiology survey, health examination, understanding Susceptible population.
Hepatitis A virus IgG antibody test in laboratory method is mainly immunoassay, and conventional detection method is radiommunoassay (RIA) and EIA enzyme immunoassay (EIA).That current use is the widest is EIA enzyme immunoassay (EIA).
The investigation and application development of labelling immunoassay technology in recent years rapidly, has been widely used in biomedical fundamental research and each field of clinical disease diagnosis.Be easy to mainly containing of popularization: radiommunoassay, EIA enzyme immunoassay, time resolved fluoro-immunoassay and chemiluminescence immune assay etc. four kinds.The basic theories of these ultramicron detection techniques is substantially identical, but tracer agent used and the signal that sends different.According to a large amount of test findings and clinical practice data, from practicality, stability, accuracy and development prospect, be followed successively by: chemiluminescence immune assay, time resolved fluoro-immunoassay, radiommunoassay and EIA enzyme immunoassay.Chemiluminescence immunoassay technology, both there is the high sensitivity of the method such as radiommunoassay, time resolved fluoro-immunoassay, the advantage that the range of linearity is wide, overcomes again the radioactive contamination of radiommunoassay, the half life period short and shortcoming such as time resolved fluoro-immunoassay poor stability, expensive equipment.
But chemiluminescence immune assay hepatitis A virus IgG antibody kit also has shortcoming, requirement is had to operating ambient temperature, operating ambient temperature is high, just affect the measuring accuracy of kit, and operating ambient temperature is too low, then can have a strong impact on the running status of whole kit, even kit is scrapped.Especially in the winter time, without heating installation without in the working environment of air-conditioning, very easily break down or quality problems.
In addition, need in kit to place plurality of reagents bottle, easily collide between each reagent bottle, in prior art, adopt groove to settle reagent bottle, but common standing groove cannot adapt to the placement of reagent bottle not of uniform size.
Utility model content
In order to solve the problem, the utility model provides one can the different size reagent bottle of flexible adaptation, and ensures the kit for detecting hepatitis A virus IgG antibody of laying temperature.
The utility model is by the following technical solutions:
A kind of kit for detecting hepatitis A virus IgG antibody, comprise box body and lid, described box body inner bottom part is provided with reagent bottle placement section, and described placement section is provided with multiple standing groove, and described standing groove is surrounded by riser, described riser is along the slide on box body side, described box body and lid inside surface are equipped with heat-insulation layer, be provided with heating arrangement, be provided with power supply in lid in described lid, also be provided with temperature sensor in lid, described temperature sensor is connected with heating arrangement.
Preferably, described heat-insulation layer is eps foam.
Described detection hepatitis A virus IgG antibody agents useful for same bottle comprises hepatitis A virus IgG antibody negative controls reagent bottle, hepatitis A virus IgG antibody positive reference substance reagent bottle, hepatitis A viral antigen liquid reagent bottle, the anti-HAV reagent bottle of acridinium ester label, alkaline luminous substrate reagent bottle and thickening and washing reagent bottle.
Advantage of the present utility model and beneficial effect are:
The utility model adopts riser to surround standing groove, the size of adjustable standing groove, facilitates the firm placement of different size reagent bottle;
The utility model adopts heat-insulation layer and heating arrangement, can promote the temperature in kit, and temperature sensor effectively controls power supply, and when temperature in kit reduces, temperature sensor controls heating arrangement and heats, the temperature in real-time ensuring kit.
Accompanying drawing explanation
Fig. 1 is box body structure schematic diagram of the present utility model;
Fig. 2 is lid structural representation of the present utility model;
Fig. 3 is the A-A cut-open view of Fig. 1.
Wherein, 1-reagent bottle, 2-riser, 3-box body, 4-standing groove, 5-heating arrangement, 6-power supply, 7-temperature sensor, 8-heat-insulation layer, 9-lid, 10-chute.
Embodiment
As shown in Figure 1 to Figure 3, a kind of kit for detecting hepatitis A virus IgG antibody, comprise box body 3 and lid 9, described box body 3 inner bottom part is provided with the placement section of reagent bottle 1, and described placement section is provided with multiple standing groove 4, and described standing groove 4 is surrounded by riser 2, described riser 2 edge is provided with projecting block, projecting block can slide along the chute 10 on box body side, to adjust the position of riser 2, adapts to the size of reagent bottle 1.
Described box body 3 and lid 9 inside surface are equipped with eps foam heat-insulation layer 8, be provided with heating arrangement 5 in described lid 9, in lid 9, be provided with power supply 6, in lid 9, be also provided with temperature sensor 7, described temperature sensor 7 is connected with heating arrangement 5, temperature in real-time inspection and control box.
Described detection hepatitis A virus IgG antibody agents useful for same bottle 1 comprises hepatitis A virus IgG antibody negative controls reagent bottle, hepatitis A virus IgG antibody positive reference substance reagent bottle, hepatitis A viral antigen liquid reagent bottle, the anti-HAV reagent bottle of acridinium ester label, alkaline luminous substrate reagent bottle and thickening and washing reagent bottle.

Claims (3)

1. one kind for detecting the kit of hepatitis A virus IgG antibody, comprise box body and lid, it is characterized in that, described box body inner bottom part is provided with reagent bottle placement section, described placement section is provided with multiple standing groove, described standing groove is surrounded by riser, described riser is along the slide on box body side, described box body and lid inside surface are equipped with heat-insulation layer, heating arrangement is provided with in described lid, be provided with power supply in lid, be also provided with temperature sensor in lid, described temperature sensor is connected with heating arrangement.
2. the kit for detecting hepatitis A virus IgG antibody according to claim 1, is characterized in that, described heat-insulation layer is eps foam.
3. the kit for detecting hepatitis A virus IgG antibody according to claim 1, it is characterized in that, described reagent bottle comprises hepatitis A virus IgG antibody negative controls reagent bottle, hepatitis A virus IgG antibody positive reference substance reagent bottle, hepatitis A viral antigen liquid reagent bottle, the anti-HAV reagent bottle of acridinium ester label, alkaline luminous substrate reagent bottle and thickening and washing reagent bottle.
CN201520782601.2U 2015-10-10 2015-10-10 Kit for detecting anti -HAV (hepatitis A virus) igG (immunoglobulin G) Expired - Fee Related CN205067498U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201520782601.2U CN205067498U (en) 2015-10-10 2015-10-10 Kit for detecting anti -HAV (hepatitis A virus) igG (immunoglobulin G)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201520782601.2U CN205067498U (en) 2015-10-10 2015-10-10 Kit for detecting anti -HAV (hepatitis A virus) igG (immunoglobulin G)

Publications (1)

Publication Number Publication Date
CN205067498U true CN205067498U (en) 2016-03-02

Family

ID=55394035

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201520782601.2U Expired - Fee Related CN205067498U (en) 2015-10-10 2015-10-10 Kit for detecting anti -HAV (hepatitis A virus) igG (immunoglobulin G)

Country Status (1)

Country Link
CN (1) CN205067498U (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111596061A (en) * 2020-05-19 2020-08-28 迪瑞医疗科技股份有限公司 Hepatitis A virus total antibody determination kit and preparation method thereof
CN112285350A (en) * 2020-11-03 2021-01-29 河南省洛阳正骨医院(河南省骨科医院) Osteosarcoma early-stage in-vitro non-invasive immunodiagnosis device and use method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111596061A (en) * 2020-05-19 2020-08-28 迪瑞医疗科技股份有限公司 Hepatitis A virus total antibody determination kit and preparation method thereof
CN112285350A (en) * 2020-11-03 2021-01-29 河南省洛阳正骨医院(河南省骨科医院) Osteosarcoma early-stage in-vitro non-invasive immunodiagnosis device and use method thereof

Similar Documents

Publication Publication Date Title
ES2298244T5 (en) Method for the detection of influenza A / B viruses in saliva
Safarpoor Dehkordi Prevalence study of Bovine viral diarrhea virus by evaluation of antigen capture ELISA and RT-PCR assay in Bovine, Ovine, Caprine, Buffalo and Camel aborted fetuses in Iran
CN204374216U (en) A kind of kit of quick detection hepatitis b virus s antigen
Dilnessa et al. Cell culture, cytopathic effect and immunofluorescence diagnosis of viral infection
CN205067498U (en) Kit for detecting anti -HAV (hepatitis A virus) igG (immunoglobulin G)
Anderson et al. Prospective surveillance for influenza A virus in Chinese swine farms
CN103509877A (en) Fluorescence quantitative PCR kit used for detecting PRV, and application thereof
CN203048945U (en) Disc type superspeed real-time fluorescence quantification polymerase chain reaction (PCR) instrument
CN104237512A (en) Immune colloidal gold test stripe and preparation method and application
CN103981283B (en) A kind of method detecting infectious bovine rhinotrachetis virus in aerosol
CN104360058A (en) Novel immunochromatography test paper for detecting human brucellosis antibody and preparing method thereof
CN102409111B (en) Detect the one-step method fluorescence RT-PCR test kit of AIV-HPAIV-NDV simultaneously
CN204241483U (en) For detecting the kit of hepatitis A virus IgG antibody
CN103981284A (en) Detection method for foot and mouth disease virus in aerosol and kit
CN208532801U (en) The relevant Epstein-Barr virus detection kit of cancer
CN104120195B (en) Single tube distinguishes PCR method and the test kit of four kinds of pathogenic agent in prenatal and postnatal care inspection
CN204241481U (en) A kind of kit for detecting antihepatitis A virus IgM
CN109082379A (en) It is a kind of for highly emulating the in vitro culture device of Nasopharyngeal neoplasms
CN202297608U (en) Detection kit for bacterial drug resistance genes
CN207876315U (en) A kind of modified form HCV virus parting detecting reagent
CN206467234U (en) Detect the PCR kit for fluorescence quantitative and system of foot and mouth disease virus
CN103789430A (en) Kit for rapid detection of eperythrozoon, leptospira and toxoplasma in blood and application of kit
Knowles et al. Efficient isolation of mumps virus from a community outbreak using the marmoset lymphoblastoid cell line B95a
CN206132781U (en) Circulating tumor cell analysis appearance
CN204241480U (en) The kit of quick detection hepatitis B virus pre S 1 antigen

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160302

Termination date: 20181010

CF01 Termination of patent right due to non-payment of annual fee